Acrodermatitis enteropathica and Rheumatoid arthritis

Summary:

Rheumatoid arthritis is reported only by a few people with Acrodermatitis enteropathica.

The study analyzes which people have Rheumatoid arthritis with Acrodermatitis enteropathica. It is created by eHealthMe based on 1 person who has Rheumatoid arthritis and Acrodermatitis enteropathica from the Food and Drug Administration (FDA), and is updated regularly.

What is Acrodermatitis enteropathica?

Acrodermatitis enteropathica (autosomal recessive disease due to a partial disorder of intestinal zinc uptake) is found to be associated with 8 drugs and 5 conditions by eHealthMe. Check the latest studies of Acrodermatitis enteropathica.

What is Rheumatoid arthritis?

Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 1,679 drugs and 2,123 conditions by eHealthMe. Check the latest studies of Rheumatoid arthritis.

On Jun, 11, 2026

1 person who has Acrodermatitis Enteropathica and Rheumatoid Arthritis is studied.

Would you have Rheumatoid arthritis when you have Acrodermatitis enteropathica?

Gender of people who have Acrodermatitis Enteropathica and experienced Rheumatoid Arthritis *:

female: 0.0 %
male: 100 %

Age of people who have Acrodermatitis Enteropathica and experienced Rheumatoid Arthritis *:

Common co-existing conditions for these people *:

High Blood Pressure: 1 person, 100.00%

Common drugs taken by these people *:

Tacrolimus: 1 person, 100.00%
Prednisolone: 1 person, 100.00%
Methotrexate: 1 person, 100.00%
Enbrel: 1 person, 100.00%
Captopril: 1 person, 100.00%

Common symptoms for these people *:

Septic Shock (shock due to blood infection): 1 person, 100.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 100.00%
Multi-Organ Failure (multisystem organ failure): 1 person, 100.00%
Mobility Decreased (ability to move is reduced): 1 person, 100.00%
Insomnia (sleeplessness): 1 person, 100.00%
Injection Site Pain: 1 person, 100.00%
Hand Deformity: 1 person, 100.00%
Fatigue (feeling of tiredness): 1 person, 100.00%
Escherichia Infection (bacterial infection by escherichia coli): 1 person, 100.00%
Device Related Infection: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rheumatoid arthritis?

- Check whether Rheumatoid arthritis is associated with a drug or a condition

Related publications that referenced our studies

Mathai, P. C., Andrade, N. N., Aggarwal, N., Nerurkar, S., & Kapoor, P. , "Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw", Oral and maxillofacial surgery, 2018 Jan .
Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
Mathai, P. C., Andrade, N. N., Aggarwal, N., Nerurkar, S., & Kapoor, P. , "Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw", Oral and maxillofacial surgery, 2018 Jan .
Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rheumatoid arthritis and Acrodermatitis enteropathica, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.